ArticleJournal for immunotherapy of cancer2024

Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab.

Ludimila Cavalcante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.